Search

ISSN: 2251-8363 eISSN: 2251-8819

J Nephropathol. 2018;7(1): 7-10. doi: 10.15171/jnp.2018.03

Short-Review

Is it the time to offer rituximab as a cost-benefit treatment for immunoglobulin A nephropathy? A short-review to current concepts

Mohammad-Reza Tamadon ¹, Jamileh Moghimi ² * , Hamed Rezaei ³

Cited by CrossRef: 0

Submit Your Paper Editorial Policly Author Guidelines Peer-Review Policy Publication Fee Publishing schedule/Archiving Editorial Board Archive

Indexing Information

Journal of Nephropathology is a member of COPE

This journal follows the guidelines of COPE

Journal of Nephropathology is a follower of the International Committee of Medical Journal Editors

We are a follower of World Association of Medical Editors